Literature DB >> 1945036

Gabapentin increases aminooxyacetic acid-induced GABA accumulation in several regions of rat brain.

W Löscher1, D Hönack, C P Taylor.   

Abstract

Gabapentin exerts anticonvulsant effects in different animal models of seizure states and in epileptic patients with different seizure types, but the mechanism of action of these effects is unknown. In the present study, the gamma-aminobutyric acid (GABA) accumulation induced by aminooxyacetic acid (AOAA) was used as a method to study the effects of gabapentin on regional turnover of GABA in the rat brain. Gabapentin was administered at a dose of 23 mg/kg i.p. (the ED95 against tonic electroconvulsions in rats) 1, 2 and 8 h prior to injection of AOAA, 100 mg/kg, i.p. Gabapentin significantly increased the AOAA-induced GABA accumulation in most of the 12 brain regions examined, but the time course of the increases in GABA accumulation differed from region to region. Regions in which the time course of the increase in GABA accumulation was similar to the anticonvulsant time course of gabapentin included substantia nigra, amygdala and thalamus. The data suggest that an effect of gabapentin on GABA synthesis might be involved in its mechanism of anticonvulsant action.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1945036     DOI: 10.1016/0304-3940(91)90249-s

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  18 in total

Review 1.  Recent advances in the development of treatments for alcohol and cocaine dependence: focus on topiramate and other modulators of GABA or glutamate function.

Authors:  Bankole A Johnson
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

Review 2.  The new generation of GABA enhancers. Potential in the treatment of epilepsy.

Authors:  S J Czuczwar; P N Patsalos
Journal:  CNS Drugs       Date:  2001       Impact factor: 5.749

3.  Pharmacological modulation of pain-related brain activity during normal and central sensitization states in humans.

Authors:  G D Iannetti; L Zambreanu; R G Wise; T J Buchanan; J P Huggins; T S Smart; W Vennart; I Tracey
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-05       Impact factor: 11.205

4.  The impact of gabapentin administration on brain GABA and glutamate concentrations: a 7T ¹H-MRS study.

Authors:  Kejia Cai; Ravi Pr Nanga; Lisa Lamprou; Claudia Schinstine; Mark Elliott; Hari Hariharan; Ravinder Reddy; C Neill Epperson
Journal:  Neuropsychopharmacology       Date:  2012-08-08       Impact factor: 7.853

Review 5.  Gabapentin. A review of its pharmacological properties and clinical potential in epilepsy.

Authors:  Karen L Goa; Eugene M Sorkin
Journal:  Drugs       Date:  1993-09       Impact factor: 9.546

6.  A case of a patient with both chorea and restless legs syndrome.

Authors:  Yoon-Kyung Shin; Seung-Chul Hong; Yon Kwon Ihn; Jong-Hyun Jeong; Jin-Hee Han; Sung-Pil Lee
Journal:  J Korean Med Sci       Date:  2008-06       Impact factor: 2.153

Review 7.  Molecular mechanisms of antiseizure drug activity at GABAA receptors.

Authors:  L John Greenfield
Journal:  Seizure       Date:  2013-05-14       Impact factor: 3.184

8.  Effects of gabapentin on cocaine self-administration, cocaine-triggered relapse and cocaine-enhanced nucleus accumbens dopamine in rats.

Authors:  Xiao-Qing Peng; Xia Li; Jie Li; P Veeraraghavan Ramachandran; Pravin D Gagare; Debarshi Pratihar; Charles R Ashby; Eliot L Gardner; Zheng-Xiong Xi
Journal:  Drug Alcohol Depend       Date:  2007-12-11       Impact factor: 4.492

Review 9.  Mechanisms of Action of Antiseizure Drugs and the Ketogenic Diet.

Authors:  Michael A Rogawski; Wolfgang Löscher; Jong M Rho
Journal:  Cold Spring Harb Perspect Med       Date:  2016-05-02       Impact factor: 6.915

Review 10.  Newer antiepileptic drugs. Towards an improved risk-benefit ratio.

Authors:  P N Patsalos; J W Sander
Journal:  Drug Saf       Date:  1994-07       Impact factor: 5.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.